本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aridis制药

0.0001
+0.0000
成交量:15.00
成交额:0.00
市值:4,457.40
市盈率:0.00
高:0.0001
开:0.0001
低:0.0001
收:0.0001
数据加载中...
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/16

重要事件披露

Form 8-K - Current report
2023/12/18

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/09/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/08

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/09/08

重要事件披露

Form 8-K - Current report
2023/08/25

重要事件披露

Form 8-K - Current report
2023/08/09

重要事件披露

Form 8-K - Current report
2023/07/31

SEC问询函

Form CORRESP - Correspondence
2023/07/31

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/26

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/20

SEC问询函

Form CORRESP - Correspondence
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]